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Somatostatin-receptor 1 (sst1) is an autoreceptor in the cen-
tral nervous system that regulates the release of somatostatin.
Sst1 is present intracellularly and at the cell surface. To in-
vestigate sst1 trafficking, rat sst1 tagged with epitope was
expressed in rat insulinoma cells 1046-38 (RIN-1046-38) and
tracked by antibody labeling. Confocal microscopic analysis
revealed colocalization of intracellularly localized rat sst1-
human simplex virus (HSV) with Rab5a-green fluorescent
protein and Rab11a-green fluorescent protein, indicating the
distribution of the receptor in endocytotic and recycling or-
ganelles. Somatostatin-14 induced internalization of cell sur-
face receptors and reduction of binding sites on the cell sur-
face. It also stimulated recruitment of intracellular sst1-HSV
to the plasma membrane. Confocal analysis of sst1-HSV re-
vealed that the receptor was initially transported within su-
perficial vesicles. Prolonged stimulation of the cells with the
peptide agonist induced intracellular accumulation of soma-
tostatin-14. Because the number of cell surface binding sites
didnot changeduringprolonged stimulation, somatostatin-14
was internalized through a dynamic process of continuous
endocytosis, recycling, and recruitment of intracellularly
present sst1-HSV. Accumulated somatostatin-14 bypassed
degradation via the endosomal-lysosomal route and was in-
stead rapidly released as intact and biologically active soma-
tostatin-14. Our results show for the first time that sst1 me-
diates a dynamic process of endocytosis, recycling, and
reendocytosis of its cognate ligand. (Endocrinology 148:
1050–1058, 2007)
THE TETRADECAPEPTIDE SOMATOSTATIN (SST)-14and the N terminally extended form, sst-28, are major
inhibitory peptideswith broad endocrine, exocrine, and neu-
ronal functions (1). The biological actions of somatostatin are
mediated by five G protein-coupled receptors (GPCRs) (sst1,
sst2, sst3, sst4, and sst5) (reviewed in Ref. 1). These receptor
subtypes share common signaling pathways, which include
inhibiting adenylyl-cyclase and modulating MAPK through
G protein-dependent mechanisms (reviewed in Refs. 2 and
3). sst1 and sst2 also couple to voltage-dependent Ca2 chan-
nels, tyrosine phosphatase SHP-1, and phospholipase A2
(4–8).
Several observations suggest that sst1 is an autoreceptor
regulating the release of its own peptide agonist, somatosta-
tin. The presence of sst1 mRNA in the periventricular nu-
cleus of the hypothalamus, which is rich in somatostatin,
suggests that both receptor and peptide colocalize, which
may indicate an autoregulative function of the receptor (9,
10). Furthermore, the receptor and peptide colocalize in the
somatostatinergic paraventricular neuronal system and in
the retina of the rat (11, 12). Functional studies with receptor
subtype-specific agonists or mice in which the sst1 gene is
deleted underscore the autoregulative function of sst1 (13,
14).
We previously found that sst1 and sst2 are endogenously
expressed in the rat insulinoma cell line 1046–38 (RIN 1046–
38) (4). Displacement binding analysis andRT-PCR indicated
that sst1 is the major somatostatin receptor subtype ex-
pressed in this cell line, in which it functionally couples to
voltage-dependent Ca2 channels (4, 15). Stimulation of
epitope-labeled recombinant rat sst1-HSVwith somatostatin
induces loss of cell surface-binding sites in these cells, which
is indicative of receptor endocytosis (15). sst1 has also been
internalized in HEK293 cells (16), although some groups
have shown that somatostatin either does not induce sst1
receptor endocytosis or causes very slow internalization
[half-time (T1/2) 180min] of this receptor (15–20). Thus, the
possible mechanisms of endocytosis of sst1 are unknown.
Most studies of agonist-induced endocytosis of GPCRs
have focused on clathrin-dependent mechanisms that in-
volve dynamin and the clathrin adaptor molecule -arrestin
(reviewed inRef. 21). Recently endocytosis of sst1was shown
not to be mediated by -arrestin (22).
Here we report on the trafficking of sst1 and its cointer-
nalized peptide agonist SST-14. Our findings indicate that
peptide stimulation induces a fast dynamic process of en-
docytosis, recycling, and reendocytosis of the receptor and
the ligand. SST-14 is not routed to lysosomal degradation; the
ligand is continuously internalized and released as intact and
First Published Online December 14, 2006
* W.M. and M.S. contributed equally to this work.
Abbreviations: EGFP, Enhanced green fluorescent protein; FITC, flu-
orescein isothiocyanate; GPCR, G protein-coupled receptor; HSV, hu-
man simplex virus; sst, somatostatin-receptor; SST, somatostatin; T1/2,
half-time.
Endocrinology is publishedmonthly by The Endocrine Society (http://
www.endo-society.org), the foremost professional society serving the
endocrine community.
0013-7227/07/$15.00/0 Endocrinology 148(3):1050–1058
Printed in U.S.A. Copyright © 2007 by The Endocrine Society
doi: 10.1210/en.2006-1600
1050
biological active SST-14 in themedium, in which it is cleaved
by endopeptidases sensitive to phosphoramidon. Our find-
ings also indicate that intracellular sst1 is involved in recep-
tor-mediated uptake of SST-14.
Materials and Methods
Materials
SST-14 was obtained from Saxon Biochemicals (Bissendorf, Ger-
many). 125I-Tyr11-SST-14 was from Amersham (Braunschweig, Ger-
many) and FITC-labeled SST-14 was obtained from Advanced Biocon-
cept (Derry, Canada). Mouse antihuman simplex virus (HSV)
glycoprotein D monoclonal antibodies were purchased from Novagen
(Madison, WI). Media, sera, and plastics were from Life Technologies,
Inc./BRL (Eggenstein, Germany). Lipofectamine 2000 was from Invitro-
gen (Karlsruhe, Germany). Unless otherwise specified, all other reagents
were from Sigma (St. Louis, MO).
Generation of cDNA constructs and cell lines
All experiments used the rat insulinoma cell line 1046–38. This cell
line endogenously expresses sst1endo with a maximal binding capacity
of 31 ( 7) fmol per 2  104 cells. Sst1endo is functionally coupled to
adenylyl-cyclase and voltage-dependent Ca2 channels in these cells (4,
15). RIN-sst1-HSV cells were maintained in RPMI 1640 medium con-
taining 400 g/ml G418 and demonstrated a maximal binding capacity
of 840 ( 90) fmol per 2  104 cells (15). Plasmids encoding sst1-HSV,
and Rab5a-enhanced green fluorescent protein (EGFP), Rab11a-EGFP
have been described (15, 23–25). RIN-sst1-HSV cells were transiently
transfected with Lipofectamine 2000 and used 48 h after transfection.
Reduction of cell surface binding
Cells grown in 24-well dishes were stimulated with 1 m SST-14 in
RPMI 1640 medium (0.1% BSA) for 0–120 min at 37 C. Cells were placed
on ice, washed three timeswith chilled acidic buffer, and incubatedwith
100,000 cpm per 0.3 ml 125I-Tyr11-SST-14, 0.01 nm SST-14, 0.1% BSA in
RPMI 1640 medium, at 4 C for 90 min (15). Bound 125I-Tyr11-SST-14 was
collected after lysing of the cells in 1 ml 1 m NaOH and determined in
a -counter (Canberra Packard, Dreieich, Germany). Calculations and
graphical presentation were carried out using Excel. Unspecific binding
was determined in the presence of 0.1 mm SST-14.
Receptor-mediated uptake of 125I-Tyr11-SST-14
RIN-sst1-HSV cells grown in 24-well microtiter dishes were incu-
bated with 100,000 cpm per 0.3 ml 125I-Tyr11-SST-14 mixed with 0.01 nm
SST-14 in RPMI 1640 medium (0.1% BSA) at 37 C in the presence or
absence of 40 mm ammonium chloride (pH 7.4), monensin (50 m), or
sucrose (0.45 m) (26). After 0–120 min, the cells were placed on ice and
washedwith chilled acidic buffer [Hank’s salt solution, 20mm acetic acid
(pH 4.75)] (15). Cells were lysed in 1 m NaOH and radioactivity was
measured in a -counter.
Displacement binding assay
Cells, seeded in 24-well microtiter plates, were incubated on ice with
100,000 cpm per 0.3 ml 125I-Tyr11-SST-14 containing indicated concen-
trations of unlabeled SST-14 in RPMI 1640 medium and 0.1% BSA at 4
C for 90 min. Cells were washed with chilled RPMI 1640 and 0.1% BSA,
lysed in 1 ml 1 m NaOH, and surface-bound 125I-Tyr11-SST-14 was
determined in a -counter.
Displacement uptake assay
Cells, seeded in 24-well microtiter plates, were stimulated with
100,000 cpmper 0.3ml 125I-Tyr11-SST-14 containing 0.01–1000 nm SST-14
in RPMI 1640 medium and 0.1% BSA at 37 C for 75 min. Cells were
washed with chilled acidic buffer (pH 5.0), lysed in 1 m NaOH, and
cell-associated radioactivity determined in a -counter.
HPLC analysis of 125I-Tyr11-SST-14
Cells were incubatedwith 100,000 cpm/ml 125I-Tyr11-SST-14 in RPMI
1640 and 0.1%BSA in the presence or absence of 10m phosphoramidon
at 37 C. After 10 min of stimulation, cells were placed on ice and washed
twice with chilled acidic buffer (pH 5.0) (15). Cells were washed once
with chilled RPMI 1640 and 0.1% BSA, incubated for the indicated times
at 37 C in 1 ml RPMI 1640 and 0.1% BSA, and placed on ice. The
supernatantswere collected and acidified by adding 10l trifluoroacetic
acid. The supernatants were centrifuged (5 min, 13,000  g) and sub-
jected toHPLC separation. Cell-associated radioactivitywas determined
by adding 1 ml HPLC buffer A. Lysed cells were centrifuged (5 min,
13,000  g) and subjected to HPLC separation.
HPLC was done on a reverse-phase C-18 column (2  25 mm). A
separating gradient of 0–40% acetonitrile, 0.08% trifluoroacetic acid, 25
min, 1 ml/min was performed with a HPLC-Model Gold (Beckman,
Krefeld, Germany). The HPLC gradient was fractionated every minute,
and the eluted radioactivity was determined in a -counter (27, 28). The
radioactivity of each fraction was divided by the initial amount of
cell-associated radioactivity determined after 10 min of incubation with
100,000 cpm/ml 125I-Tyr11-SST-14.
Recycling of 125I-Tyr11-SST-14
Cells were stimulated with 100,000 cpm/ml 125I-Tyr11-SST-14 mixed
with 0.01 nm unlabeled SST-14 in RPMI1640 and 0.1% BSA at 37 C. After
10min, disheswere placed on ice and cellswerewashed three timeswith
chilled acidic buffer. Cells were then washed once with chilled RPMI
1640 and 0.1% BSA and incubated at 37 C. Mediumwas exchanged with
1 ml fresh temperate medium after 1, 5, 10, 15, and 30 min of incubation
and the amount of recycled radioactivity was quantified in a -counter.
Determination of SST-14-mediated inhibition of adenylyl
cyclase activity
RIN-sst1-HSV cells were stimulated for 15 min with 1 m SST-14,
placed on ice and washed twice with chilled acidic buffer and once with
chilled RPMI 1640 and 0.1% BSA. Thereafter cells were incubated at 37
C. After 10 min, supernatant was collected. The method for determining
inhibition of forskolin-stimulated adenylyl-cyclase of the supernatant
has been described elsewhere (15).
Surface biotinylation of RIN-sst1 cells
Proteins located on the cell surface were biotinylated according to
manufacturer’s instructions (Pierce, Bonn, Germany). Briefly, cells
grown on glass coverslips were placed on ice, washed with chilled PBS
adjusted to pH 8.0, and incubated for 30 min with 5 mm sulfo-NHS-
LC-biotin (Pierce) in PBS (pH 8.0) at 4 C. Thereafter the cells were
washed once with PBS (pH 8.0) and 50mm glycine and thenwith chilled
RPMI 1640 and 0.1% BSA. They were then stimulated with SST-14 (10
nm). The localization of sst1-HSVwas analyzed by confocal microscopy.
Microscopy and immunofluorescence
Cellswere stimulatedwith 10 nm SST-14 or fluorescein isothiocyanate
(FITC)-SST14 in RPMI 1640 medium and 0.1% BSA for the indicated
times at 37 C, washed with Hank’s-buffered saline/acetic acid (pH 4.75)
at 4 C, fixed, and permeabilized for 30min inHank’s-buffered saline, 5%
normal goat serum, and 0.05% saponin. sst1-HSVwas detected by using
mouse anti-glycoprotein D antibody (1:10,000, overnight at 4 C). Bio-
tinylated proteinswere detected by using Texas Red-conjugated strepta-
vidin (1:2000, 1 h, room temperature), Rab-proteins by using green
fluorescent protein fluorescence, and SST-14 by FITC-SST-14. FITC-con-
jugated or Texas Red-conjugated goat antimouse IgG was used as sec-
ondary antibodies (1:200, 1 h, room temperature). Cells were embedded
in Vectashield mounting medium (Vector, Burlingame, CA) and ob-
served with confocal microscopy (15).
Results
Acidic washes remove surface-bound ligand
To differentiate between cell surface-bound and cell-as-
sociated 125I-Tyr11-SST-14, cells were washed with chilled
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acidic buffer. The effect of acid treatment on RIN-sst1-HSV
cells stimulated at 37 C or incubated at 4 C with 100,000 cpm
125I-Tyr11-SST-14 is shown in Table 1. Cell surface-bound
125I-Tyr11-SST-14 was nearly completely removed after three
washes, whereas cell-associated 125I-Tyr11-SST-14 was lo-
cated in acidic wash-resistant compartments (Table 1).
Stimulation with SST-14 induced loss of cell surface
binding sites
We determined the specificity of sst1 internalization by
quantification of the agonist-induced loss of cell surface
binding sites in untransfected RIN-1046–38 cells (Fig. 1A)
and RIN-1046–38 stable expressing sst1-HSV (Fig. 1B). At 4
C, unstimulatedRIN-1046–38 cells bound approximately 800
( 250) cpm per 2  104 cells, whereas unstimulated RIN-
sst1-HSV cells bound more than 10 times as much ligand
[approximately 8500 ( 250) cpmper 2 104]. After exposure
to SST-14, cell surface binding sites rapidly decreased in both
cell lines. During the first 2–5 min of stimulation, binding
sites dropped to 50% of the original value and remained at
this level throughout the experiment.
sst1 mediates uptake of 125I-Tyr11-SST-14
Receptor-mediated uptake of 125I-Tyr11-SST-14 was char-
acterized by chronic stimulation of the cells with the agonist.
During the first 2–3 min of stimulation, RIN-1046–38 cells
accumulated approximately 400 cpm per 2  104 cells,
whereas RIN-sst1-HSV cells accumulatedmore than 10 times
that much (5000 cpm per 2  104; Fig. 1, C and D). After 2–3
min of stimulation, the amount of accumulated radioactivity
was equivalent to 50% of surface-bound 125I-Tyr11-SST-14 at
4 C (compare Fig. 1, A and B, with Fig. 1, C and D). After 75
min of stimulation, cell-associated radioactivity reached the
maximal level of 220% of the cell surface binding sites (Fig.
1, C and D). These results show that recombinant sst1-HSV
and endogenously expressed sst1 demonstrate identical ki-
netics concerning loss of cell surface binding sites and re-
ceptor-mediated uptake of the ligand. They also indicate that
epitope-labeled sst1-HSV and endogenously expressed sst1
behave identically.
To further characterize the sst1-specific uptake of SST-14
we stimulated the cells in the presence of 0.45 m sucrose,
which inhibits the clathrin-mediated and the caveolin-
mediated receptor endocytosis (29, 30). We found that su-
crose nearly completely inhibited sst1-mediated uptake of
SST-14 (Fig. 1E). Receptor trafficking was further character-
ized by neutralizing acidic cell compartments with ammo-
nium chloride (26). We found that sst1-mediated accumu-
lation of SST-14 was not affected, suggesting that vesicular
acidification is not important for the accumulation of SST-14
(26). Control experiments simultaneously performed in RIN-
sst3-HSV cells demonstrated that preincubation with am-
monium chloride efficiently blocked receptor trafficking and
lysosomal degradation of SST-14 and thereby changed the
kinetics of sst3-mediated uptake of SST-14 (data not shown).
To inhibit trafficking of sst1 from perinuclear membrane
structures, the Golgi apparatus and post-Golgi endosomes
were disrupted by the cationophor monensin (31). Monensin
(50 m) markedly inhibited sst1-mediated accumulation of
SST-14, even at early time points of stimulation (Fig. 1E),
suggesting that recruitment of intracellular sst1-HSV is
needed for continuous accumulation of the ligand. To in-
vestigate whether monensin or sucrose influenced receptor
surface binding, RIN-sst1-HSV cells were incubated with
monensin or sucrose (Fig. 1F) and surface binding sites were
determined by incubating the cells with 100,000 cpm 125I-
Tyr11-SST-14 for 90min at 4 C. Treatmentwithmonensin and
sucrose did not change surface binding sites of RIN-sst1-HSV
(Fig. 1F), which suggests that the induced recruitment of
intracellular sst1 is essential for the continuous accumulation
of the ligand.
Displacement binding assays
To further clarify the process of sst1-mediated uptake of
SST-14, we performed displacement binding assays at 4 C
and displacement uptake assays at 37 C (Fig. 1G). At all
concentrations of SST-14, the amount of cell-associated 125I-
Tyr11-SST-14 was approximately 2.2 times the amount of cell
surface-bound ligand. The Scatchard plot (not shown) dem-
onstrated a dissociation constant(4 C) of 2.5  1.0 nm and
dissociation constant(37 C) of 2.5  1.0 nm. The cell surface-
binding sites for RIN-sst1 cells were determined to be 840 
90 fmol per 2  104 cells, whereas the maximal amount of
accumulated SST-14 was determined to be 1750  110 fmol
per 2  104 cells.
Comparison of the kinetics of the agonist-induced loss of
cell surface binding sites and the sst1-mediated uptake of
SST-14
Both methods are used to determine agonist-induced in-
ternalization of sst1 (15, 17, 20). Therefore, we merged the
curves obtained from agonist-induced loss of cell surface
binding sites (Fig. 1B) and the curve from sst1-mediated
uptake of SST-14 (Fig. 1D). After 2–3min of stimulation, both
curves crossed at approximately 4700 cpm (Fig. 1H, arrow);
4700 cpm is equal to 50% of cell surface bound ligand of
unstimulated cells. Therefore, after approximately 3 min of
incubation 50%of ligand occupied sst1 are internalizedwhen
stimulated with 1 m SST-14 (Fig. 1B). Moreover, 50% of
ligand occupied sst1 are internalized when stimulated with
0.01 nm SST-14 (Fig. 1D). Therefore, the process of agonist-
induced internalization of sst1 is independent from the con-
centration of the ligand. To determine t1/2 for the receptor
mediated uptake of SST-14, the initial speed of this process
was linearized by setting a tangent (Fig. 1D, dotted line). We
calculated t1/2  2.0 min for this process. Interestingly, after
3min of stimulation, the amount of cell-associated 125I-Tyr11-
SST-14 exceeded 4700 cpm. This observation indicates a dy-
TABLE 1. Removal of surface-bound peptide by acidic washes.
Temperature (C) Bound (cpm) Acidic extractable (%)
37 22.400  400 21  1
4 8.500  250 96  3
RIN-sst1-HSV cells were incubated with 125I-Tyr11-SST-14
(100,000 cpm) for 90 min at the indicated temperature. The amount
of bound 125I-Tyr11-SST-14 was then determined before and after
treatment of the cells with three acidic washes Hank’s salt solution,
20 mM acetic acid (pH 4.75), as described inMaterials and Methods.
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FIG. 1. SST-14-induced endocytosis of sst1. SST-14-mediated reduction of cell surface binding sites (A and B). RIN-1046–38 cells (A) and
RIN-sst1-HSV cells (B) were stimulated with SST-14 (1 M) at 37 C for the indicated times. After three acidic washes, cell surface binding sites
were determined by incubating the cells with 100,000 cpm radioactive SST-14 at 4 C. During the first 2–3min after stimulation, SST-14 induced
a 50% loss of cell surface binding sites. sst1 mediated accumulation of SST-14 (C and D). RIN-1046–38 cells (C) and RIN-sst1-HSV cells (D)
were incubated at 37 C with 125I-Tyr11-SST-14 for the indicated time points. Surface-located 125I-Tyr11-SST-14 was washed off with three acidic
washes, and the amount of cell-associated radioactivity was determined in a -counter. sst1-HSV-specific uptake of 125I-Tyr11-SST-14 in the
presence of ammonium chloride (circles), monensin (triangles), and sucrose (diamonds) (E). Cells were stimulated at 37 C with 100,000 cpm
125I-Tyr11-SST-14 in the presence of ammonium chloride (40 mM), monensin (50 M), or sucrose (0.45 M) for the indicated time points. After
three acidic washes, cell-associated radioactivity was determined. sst1-specific uptake of 125I-Tyr11-SST-14 was not influenced through
neutralization of acidic vesicles by ammonium chloride. Treatment of cells with monensin inhibited accumulation of 125I-Tyr11-SST-14.
Stimulation of cells in the presence of sucrose almost completely blocked uptake of 125I-Tyr11-SST-14. F, Influence of monensin (circles) and
sucrose (triangles) on cell surface binding sites. Cells were stimulated with monensin (50 M) or sucrose (0.45 M) at 37 C for the indicated times.
Cells were washed and cell surface binding sites were determined by incubation with 125I-Tyr11-SST-14 at 4 C. Cell surface binding sites did
not change during incubation with monensin or sucrose. G, Displacement of 125I-Tyr11-SST-14 cell surface binding and uptake by unlabeled
somatostatin in RIN-sst1-HSV cells. Radioactive labeled SST-14 was mixed with the indicated concentration of unlabeled SST-14. Open circles
show cell surface binding of 125I-Tyr11-SST-14 (90 min, 4 C). Closed circles show the specific amount of cell-associated radioactivity after
stimulation (75min, 37 C). The amount of cell-associated radioactivity was 2.2 times the amount of specifically surface-bound 125I-Tyr11-SST-14.
Comparison of sst1-mediated uptake of 125I-Tyr11-SST-14 and SST-14 induced loss of cell surface binding sites (H). Data from B and D were
merged. After 2–3 min, both graphs crossed at approximately 4700 cpm (arrow), which is equal to 50% of surface binding sites of unstimulated
cells (arrow). Dotted line demonstrate the tangent of the initial uptake process. Errors are smaller than the symbols.
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namic process. The data led us to conclude either that agonist
stimulation induced rapid mobilization of intracellular sst1
or that one cycle of sst1 endocytosis and recycling takes place
within this period of time.
SST-14 accumulates as intact peptide
The internalized radioactive peptides were characterized
by HPLC. Figure 2A displays the time-dependent distribu-
tion of radioactive products that were found in the super-
natant of RIN-sst1-HSV cells orwere extracted from them.At
all time points investigated, only 125I-Tyr11-SST-14 was de-
tected cell-associated (Fig. 2, closed circles). Cell-associated
125I-Tyr11-SST-14 and reference 125I-Tyr11-SST-14 eluted at
20–21 min (data not shown). The amount of accumulated
125I-Tyr11-SST-14 rapidly dropped after replacement of the
medium and then moderately declined during prolonged
incubation times. This decrease in the quantity of intracel-
lular peptide paralleled the increasing concentrations of in-
tact peptide in the extracellular medium. During the first 5
min of incubation, cells released 35% of the internalized
125I-Tyr11-SST-14 into the supernatant (Fig. 2A). The 125I-
Tyr11-SST-14 detected in the supernatant rapidly dissociated
from the cells at pH 7.4. The amount of extracellular 125I-
Tyr11-SST-14 slowly decreased during further incubation.
Concomitant with this decrease, a radioactive-labeled deg-
radation product of 125I-Tyr11-SST-14 was detected in the
supernatant from 5 min after the incubation period onward
(Fig. 2A). The amount of degraded peptide increased to 44%
at 60 min of incubation. The degraded radioactive-labeled
peptide (elution time 10–11 min) was likely obtained
through hydrolysis of 125I-Tyr11-SST-14 by a neutral endo-
peptidase-like activity (27, 28). During chronic stimulation,
SST-14 accumulated as intact SST-14 in the cells and was
released as intact peptide into the extracellular medium. The
released peptide was extracellularly degraded by endopep-
tidase-like activity. No radioactive degradation products
could be detected cell-associated indicating that SST-14 did
not lead to lysosomal degradation. These results suggested
that during stimulation, SST-14 is dynamically endocytosed,
recycled and reendocytosed as intact peptide. To explore this
further, the incubationmediumwas repeatedly exchanged to
suppress reendocytosis of the ligand under conditions in
which SST-14 degradation was blocked by pretreatment of
the cells with phosphoramidon to inhibit neutral endopep-
tidase-like activity. No radioactive degradation products
were detected in the supernatant (Fig. 2B).
During repeated exchange of the medium, 22% (3%) of
cell-associated SST-14was detected after 1min, and 77 (4%)
after 30 min of incubation. Thus, these conditions allowed
significantly more SST-14 to recycle into the medium. Taken
together, these results indicate that recycled SST-14 was re-
endocytosed. In addition, the release of intact SST-14 under-
scores the observation that SST-14 does not lead to lysosomal
degradation. The ligand is degraded by an endopeptidase
sensitive to phosphoramidon.
Recycled SST-14 is biologically active
The HPLC results indicated that recycled SST-14 elutes at
the same time as intact SST-14. To verify that recycled SST-14
is biologically active, the supernatant was tested to inhibit
forskolin-stimulated adenylyl-cyclase activity.We compared
the biological activity of the final washing buffer after stim-
ulating RIN-sst1-HSV cells with SST-14 (1 m, 10 min, 37 C)
and the medium after 10 min of recycling (Fig. 2C). Only the
culture medium from RIN-sst1-HSV cells inhibited cAMP
formation by 92.9% (4.5%); the washing medium was in-
effective and reduced cAMP formation by only 7% (2%).
This finding supports the results we obtained byHPLC. Both
sets of results indicate that intact and biologically active
FIG. 2. Characterization of the cell-associated radioactivity. Distri-
bution of 125I-Tyr11-SST-14 between RIN-sst1-HSV cells and the ex-
tracellularmedium (A). Cells were stimulatedwith 125I-Tyr11-SST-14
(10 min, 37 C), washed with acidic buffer, and incubated for the
indicated time points at 37 C. Closed circles, 125I-Tyr11-SST-14 in the
cellular lysate; open circles, 125I-Tyr11-SST-14 in the extracellular
medium; triangles, 125I-Tyr11-SST-14 degradation product in the ex-
tracellular medium. Cell-associated 125I-Tyr11-SST-14 was rapidly
released as intact SST-14 and was slowly degraded in the medium.
Distribution of 125I-Tyr11-SST-14 between RIN-sst1-HSV cells and
the extracellular medium after repeated refreshing of medium (B).
Cells were stimulated with 125I-Tyr11-SST-14 (10 min, 37 C) and
washed with acidic buffer. To demonstrate that released 125I-Tyr11-
SST-14 was reendocytosed by sst1, extracellular medium was re-
freshed at the indicated time points. Significantly more 125I-Tyr11-
SST-14 was found extracellularly after the medium was repeatedly
refreshed. Determination of the biological activity of recycled SST-14
(C). RIN-sst1-HSV cells stimulated with SST-14 (1 M, 15 min, 37 C),
were washed three times with acidic buffer and incubated for 10 min.
The biological activity of recycled SST-14 was determined by inhibi-
tion of forskolin-stimulated adenylyl-cyclase in RIN-sst3 cells. The
washingmedium did not inhibit adenylyl-cyclase (gray bar). Recycled
SST-14 was biologically active (black bar).
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SST-14 accumulates during chronic stimulation and is spe-
cifically released from RIN-sst1-HSV cells.
Agonist-induced trafficking of sst1-HSV
sst1-mediated uptake of FITC-SST-14.Our results did not allow
us to clearly differentiate whether the dynamic process of
sst1-mediated uptake of SST-14 was performed by rapid
recycling of sst1 or by mobilization of intracellular sst1.
Therefore, we analyzed sst1 trafficking by localizing FITC-
SST-14 with confocal microscopy (Fig. 3A). Incubation at 37
C induced a significant uptake of FITC-SST-14. At all time
points, FITC-SST-14 was observed in compartments located
directly beneath the plasma membrane, suggesting that
SST-14 accumulated in superficial vesicles. These findings
are in line with uptake assays of FITC-SST-14 mediated by
the human sst1 obtained in COS-7 cells (18).
SST-14 induced endocytosis of sst1-HSV. In untreated cells, sst1
demonstrated an intense intracellular distribution, which
prevented microscopic discrimination of endocytosed sst1-
HSV from intracellular sst1-HSV (15, 19, 22). To circumvent
this problem, the plasma membrane proteins were biotinyl-
ated in vivo before we stimulated endocytosis of sst1. Thus,
endocytosed proteinswere detected by Texas Red coupled to
streptavidin and sst1-HSV was detected by the FITC fluo-
rescence of the sst1-HSV immunostaining (Fig. 3B). In un-
treated cells (30 min, 37 C, without SST-14), sst1-HSV was
localized at the cell surface and in intracellular organelles,
whereas biotinylated surface proteins were exclusively lo-
cated at the cell surface (Fig. 3B, top panels). Localization of
sst1-HSV in nonstimulated cells is in linewith previous stud-
ies (15, 19, 22). Biotinylated proteins and sst1-HSV were
observed colocalized in superficial vesicular compartments
15 min after stimulation with SST-14 (Fig. 3B, middle panels).
Biotinylated proteins and sst1-HSV remained colocalized in
superficial vesicular compartments at the cell surface 30 min
after stimulation and were also found colocalized in vesicles
scattered throughout the cell (Fig. 3B, bottom panels). Biotin-
ylated proteins and sst1-HSV were located in superficial
vesicles in a similar way as internalized FITC-SST-14 (Fig.
3A). In marked contrast to endocytosed FITC-SST-14, inter-
nalized proteins were detected scattered throughout the cell.
These findings suggest that the internalized proteins sepa-
rate from SST-14 in superficial vesicles or that FITC-SST-14
is not transported in the same way as the unlabeled ligand.
Biotinylated proteins and sst1-HSV were transported into a
superficial cell compartment (Fig. 3, C and D).
Intracellular sst1 is located in endocytic and recycling
vesicles
To further evaluate the subcellular localization of intra-
cellular sst1-HSV, RIN-sst1-HSV cells were transiently trans-
fected with EGFP-coupled Rab5a and Rab11a. The function
of Rabproteins in the conventional endocytosis and recycling
pathway are well understood. Rab proteins are small GT-
Pases that are involved in the formation of organized mem-
brane domains. Rab proteins cycle between an active, GTP-
bound and an inactive, GDP-bound state. Rab5a functions as
a regulatory factor in the early endocytic pathway (32) and
participates in endocytosis and intracellular trafficking of
receptors as well as the fusion of early endosomes (33–35).
Expression of inactive, GTP-binding-deficient Rab5aS34N
partially inhibit translocation of transferrin from the plasma
membrane to endosomes and cause accumulation of the neu-
rokinin receptor 1 in vesicles located beneath the plasma
membrane.
Rab11a is used as a marker protein for recycling vesicles
and mediates the vesicular transport from late endosomes
and early sorting endosomes to the plasma membrane.
Rab11a also mediates the induced transport of vesicles from
the Golgi apparatus to the plasma membrane (24, 36, 37).
Expression of wild-type Rab11a and GTP-binding-deficient
Rab11aS25N markedly impeded resensitization of neuroki-
nin receptor 1. Therefore, we sought to investigate sst1-HSV
trafficking by overexpressing cells with Rab5a-EGFP and
Rab11a-EGFP.
Rab5a-mediated trafficking of sst1-HSV. In untreated cells,
Rab5a-EGFP was present in perinuclear vesicular structures
(Fig. 4). Although our earlier experiment showed that sst1-
HSV was present at the cell surface and in intracellular com-
partments, under these conditions we found that sst1-HSV
substantially colocalized with Rab5a-EGFP. Overexpression
of Rab5a-EGFP markedly changed the distribution and size
of sst1-HSV vesicles. Compared with untransfected cells,
sst1-HSV appeared in larger vesicles concentrated at the
perinuclear region.
FIG. 3. FITC-SST-14 and sst1-HSV internalized into a superficial
compartment. Uptake of FITC-SST-14 into a superficial cell com-
partment (A). RIN-sst1-HSV cells were stimulated for 90 min on ice
with FITC-SST-14 (10 nM) and incubated for the indicated time points
at 37 C. FITC-SST-14 accumulated within compartments localized
directly beneath the plasma membrane (arrows). SST-14 induced
internalization of cell surface-biotinylated proteins (B). Cells were
stimulated with SST-14 (10 nM) for the indicated time points. Red,
Surface proteins; green, sst1-HSV. The right panels demonstrate the
overlay of both images. In untreated cells, sst1 was localized in in-
tracellular vesicular compartments (arrowheads) and at the cell sur-
face (arrows). After treatment with SST-14, cell surface proteins were
transported from the cell surface into a cellular compartment local-
ized directly beneath the plasma membrane (yellow, arrowheads).
After 30 min, biotinylated proteins were transported from the cell
surface into vesicles scattered throughout the cytoplasm (arrow-
heads). C, Higher magnification of nonstimulated cells. D, Higher
magnification of a cell 30 min after stimulation with SST-14. Arrow-
heads indicate internalized sst1 present immediately beneath the cell
membrane. Bar, 10 m.
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Stimulation with SST-14 did not markedly change the lo-
calization of Rab5a-EGFP but did change the localization of
sst1-HSV, which was present in vesicles scattered through-
out the cytoplasm (Fig. 4). These vesicles did not colocalize
with the early endosome marker, Rab5a. sst1-HSV was also
found at the cell surface under these conditions.
The pattern of sst1 trafficking was distinctly altered by
coexpression of Rab5aS34N-EGFP (Fig. 4). In untreated cells,
sst1 was localized at the cell surface and in vesicular struc-
tures. Rab5aS34N-EGFP was diffusely distributed in cyto-
plasmic vesicles, in which it partially colocalized with sst1.
After stimulation with SST-14, internalized and intracellular
sst1-HSV was found trapped and strongly associated within
Rab5aS34N-EGFP-positive compartments. Expression of
GTP-binding-deficient Rab5aS34N markedly changed sst1
trafficking. In cells expressing Rab5aS34N, surface localiza-
tion of sst1 was lower than in cells that did not express
Rab5aS34N (Fig. 4).
The results we obtainedwith confocal microscopy showed
that intracellular sst1-HSV was partially colocalized with
Rab5a, indicating its distribution in endocytic vesicles. Ex-
pression of GTP-binding-deficient Rab5aS34N strongly in-
hibited the intracellular vesicular transport of sst1-HSV. Ex-
pression of Rab5aS34N did not block receptor endocytosis.
The distribution of sst1-HSV and Rab5aS34N within com-
partments localized beneath the cell membrane clearly dem-
onstrates that Rab5a participates in sst1 trafficking. Because
internalized and intracellular sst1 was found trapped and
strongly associated within Rab5aS34N-EGFP-positive com-
partments, we suggest that stimulation with the agonist has
recruited intracellular sst1-HSV to the plasma membrane
and that continuous stimulation induced internalization of
recruited sst1 and trapping of internalized sst1.
Rab11a mediated trafficking of sst1. In untreated cells, Rab11a
was present in perinuclear vesicles and in vesicles located
directly beneath the plasmamembrane (Fig. 4). sst1-HSVwas
present at the cell surface and partially colocalized with
Rab11a in perinuclear and superficial compartments (Fig. 4).
Here it substantially colocalized with Rab11a-EGFP. Over-
expression of Rab11a-EGFP markedly changed the distribu-
tion and size of sst1-HSV vesicles. Compared with RIN-sst1-
HSV cells, sst1-HSV was localized within larger vesicles
located in a perinuclear compartment. After 30 min of stim-
ulation, sst1-HSV was markedly redistributed from the
plasmamembrane to Rab11a-positive compartments (Fig. 4).
Expression of Rab11a-EGFP clearly altered trafficking of sst1-
HSV. Cell surface location of sst1-HSV was markedly di-
minished by overexpression of Rab11a. Sst1-HSV remained
colocalized within Rab11a-positive vesicles.
Expression of Rab11aS25N did not significantly affect en-
docytosis and trafficking of sst1. In nonstimulated cells,
Rab11aS24N was diffusely located in the cytosol and large
vesicular-like structures surrounding the perinuclear com-
partment of the cell (Fig. 4). sst1 was located at the cell
membrane and in small vesicles scattered throughout the
cytoplasm. sst1 immunoreactivity is slightly enhanced
within Rab11aS34N-positive vesicles. Stimulation with
SST-14 did not significantly change the localization of
Rab11aS24N-EGFP. sst1 immunoreactivity was diminished
at the cell membrane, indicating endocytosis of the receptor.
Confocal microscopy of Rab11a and Rab11aS24N in RIN-
sst1-HSV cells showed that intracellular sst1 was also located
in the recycling pathway of those cells. The results indicate
that Rab11a participates in sst1 trafficking in both the recy-
cling of receptors from superficial vesicles and the induced
translocation of intracellular receptors to the cell surface. Our
finding that intracellular sst1-HSV colocalized with Rab5a
and Rab11a indicates that sst1-HSV is distributed in vesicles
involved in endocytosis and recycling. Furthermore, the dis-
tribution of sst1-HSV within recycling vesicles suggests that
intracellular sst1-HSV can be rapidly mobilized during stim-
ulation to restore sst1 located on the cell surface.
Discussion
This study provides evidence that agonist-induced endo-
cytosis of sst1-HSV is a dynamic process of endocytosis,
recycling, and reendocytosis of intact and biologically active
SST-14. We found that during chronic stimulation, SST-14
continuously accumulated in the cells and that accumulation
was mediated by cell surface binding sites in steady state.
This accumulation was accomplished by the mobilization of
intracellularly present receptors and by endocytosed recep-
tors that recycled to the plasmamembrane. Colocalization of
intracellular sst1-HSV with marker proteins of the endocytic
and postendocytic pathways supported the assumption that
stimulation with the agonist induced recruitment of intra-
FIG. 4. Localization of sst1-HSV with marker proteins of endocytotic
and recycling pathway. sst1-HSV (red) cells expressing Rab-EGFP
proteins (green) were stimulated for 0 or 30 min with SST-14 (10 nM).
Localization of sst1-HSV and Rab5a-EGFP, 0 min, sst1-HSV was
present at the cell surface and strongly colocalized with Rab5a in a
perinuclear compartment (arrowheads). After SST-14 stimulation,
intracellular resident sst1 was also found separated from Rab5a.
Localization of sst1-HSV and Rab5aS34N-EGFP, 0 min, sst1-HSV
was present at the cell surface and colocalized with Rab5aS34N.
Stimulation with SST-14 induced internalization of sst1-HSV. The
receptor remained colocalized with Rab5aS34N. Localization of sst1-
HSV and Rab11a-EGFP, 0 min, sst1-HSV was located at the cell
surface (arrows) and extensively colocalized with Rab11a in intra-
cellular compartments (arrowheads). After SST-14 stimulation, sst1-
HSV was localized in Rab11a-positive vesicles located directly be-
neath the plasma membrane and scattered throughout the cell
(arrowheads). sst1-HSV was not longer present at the cell surface.
Localization of sst1-HSV and Rab11a S24N-EGFP, 0 min, sst1-HSV
is located at the cell membrane and partially colocalized with
Rab11aS24N. Stimulation induced internalization of sst1-HSV. Bar,
10 m.
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cellular sst1. Interestingly, endocytosed SST-14-FITC was lo-
cated only within superficial compartments. The rapid re-
cycling of intact and biological active SST-14 after the
medium was refreshed, and the uptake of surface-located
sst1-HSV in a superficial compartment indicate that SST-14
is not routed into a lysosomal degradation pathway.
In contrast with our results in rat sst1, human sst1 did not
or only slowly mediated an uptake of somatostatin, and
stimulation of sst1 induced up-regulation of sst1 located on
the cell surface (17–20). In our study, incubation of stimu-
lated cells at 37 C allowed rapid release of internalized li-
gand. The rapid sst1-mediated uptake and reendocytosis of
SST-14, along with the observation that SST-14 rapidly dis-
sociated from the receptor in a neutral environment, indi-
cates that sst1-induced endocytosis cannot be assessed by
pulse-chase stimulation or after incubating the cells with
acidic buffer at 37 C. Therefore, we suggest that differences
in the methods used to quantify internalization of human
and rat sst1 are responsible for the reported species-specific
trafficking of sst1. This suggestion is supported by the results
of confocal microscopy, which demonstrate bright immuno-
reactivity of both human and rat sst1 within the cytoplasm
and that human and rat sst1 accumulate FITC-SST-14 into a
representative superficial compartment (15, 18, 19, 22).
The ability to internalize and recycle intact somatostatin
has also been reported for sst2a (38). We propose that the
mechanisms leading to endocytosis and intracellular traf-
ficking of sst2a are different from those reported for sst1.
Endocytosis of sst2a but not sst1 is strongly associated with
-arrestins (22). Similarly, we could not demonstrate the
involvement of -arrestin in sst1-HSV internalization (data
not shown). A comparison of both receptor subtypes with
regard to receptor-mediated uptake of radiolabeled SST and
transport of FITC-SST-14 showed that 75% of the specifically
bound radioactivity was cell associated in sst2a-expressing
cells and 20% was cell associated in sst1-expressing cells
(determined after incubating the cells for 10 min at 37 C in
acidic buffer) (18). Marked differences were found in the
pattern of receptor-mediated transport of FITC-SST-14. Thus,
sst2a transports FITC-SST-14 probably via early and late
endosomes into the perinuclear compartment, whereas sst1
mediates the transport of the FITC-labeled peptide agonist
into vesicular structures localized immediately beneath the
plasma membrane (18).
Recent data from sst1 gene-deficient mice indicate a sig-
nificant increase of somatostatin levels in the retina and
up-regulation of sst2 expression. On the basis of these data,
Dal Monte et al. (13) suggested that sst1 regulates the release
of somatostatin and that the biological function of sst1 is that
of an autoreceptor. The suggestion that sst1 controls the
release of SST is supported by immunofluorescence data
demonstrating that sst1 is preferentially localized presynap-
tically in axons containing SST and that sst1 is coexpressed
with SST-14 in amacrine cells (11, 12, 39, 40).
A common feature of GPCR adjustment is down-regula-
tion of the receptor during chronic stimulation. This was
demonstrated for sst3, themuscarinic acetylcholine receptor,
and the-adrenergic receptor (41–43). Down-regulationmay
serve to protect cells against inappropriately intense or re-
peated stimulation.
Chronic stimulation of sst1 with high concentrations of
SST-14 has not been shown to induce down-regulation of sst1
(15, 19). We suggest that chronic stimulation may not induce
down-regulation of autoreceptors because down-regulation
would result in a massive release of the ligand. Furthermore,
in our study sst1 did not terminate the signal by routing the
ligand to lysosomal degradation. The peptide was rapidly
recycled as intact and biologically active SST-14. Considered
as an autoregulative function of sst1 these transport mech-
anism may assure that the internalized peptide is returned
into the extracellular fluid. By that means, the peptide ago-
nist can maintain its sustained action on the target cell.
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